Conference abstractPublished 22 Jun 2015
Abrogation of b1 integrins in combination with JNK inhibition promotes radiation resistance
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Radiation therapy remains an important modality for cancer treatment and ongoing research efforts focus on overcoming radiation resistance to improve patient survival. Here we show that fractionated radiation, 10 Gy for 5 consecutive days (50 Gy total), effectively blocks prostate tumor growth in transgenic adenocarcinoma of mouse prostate (TRAMP) mice. We have previously shown that b1 integrins suppress c-Jun amino-terminal kinase 1 (JNK1) which plays a crucial role in promoting radiation-induced apoptosis in both cancer cells and in the TRAMP model. Using a selective and reversible JNK-1, -2 and -3 inhibitor (SP600125), we demonstrate that the conditional ablation of b1 integrins in the prostatic epithelium of TRAMP mice in conjunction with JNK inhibition promotes resistance to radiation as observed in increased tumor growth. While radiation effectively suppresses tumor development in sham-treated b1 null mice, blocking JNK signaling offsets the effect of radiation resulting in increased tumor growth. We demonstrate that a prominent feature associated with tumor progression driven by JNK inhibition is the up-regulation of Focal Adhesion Kinase (FAK) signaling (enhanced levels of total and phosphorylated protein) in TRAMP prostate tumors. The JNK pathway is not active in irradiated β1 wild type TRAMP mice; as expected, upon JNK inhibition neither FAK upregulation nor tumor growth is observed. We also demonstrate that b1 integrins and FAK are found in exosomes released from prostate cancer cells, suggesting novel means of acquiring resistant phenotypes. Our study delineates a b1 integrin/JNK/FAK signaling pathway of radiation resistance in prostate cancer and identifies potential targets for facilitating development of radiosensitizing therapy against PrCa.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Aejaz Sayeed”
